Literature DB >> 54971

Natural history of benign prostatic hypertrophy and acute urinary retention.

J D Birkhoff, A R Wiederhorn, M L Hamilton, H H Zinsser.   

Abstract

Twenty-six patients with prostatism due to benign prostatic hypertrophy were evaluated prospectively every three to six months for three years. Using both subjective and objective criteria significant deterioration was demonstrated. The rate of deterioration appeared independent of prostatic size. In the individual patient progression was variable. More than half of the patients were unchanged or improved after two years. Acute urinary retention appeared independent of the degree of prostatism and therefore unpredictable. The methods can be used to evaluate medical treatments of benign prostatic hypertrophy.

Entities:  

Mesh:

Year:  1976        PMID: 54971     DOI: 10.1016/0090-4295(76)90560-4

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  13 in total

Review 1.  Benign prostatic hyperplasia.

Authors:  A Melville; J Donovon; T Sheldon; T Peters
Journal:  Qual Health Care       Date:  1996-06

Review 2.  Benign prostatic hyperplasia and its treatment.

Authors:  J B Stimson; S D Fihn
Journal:  J Gen Intern Med       Date:  1990 Mar-Apr       Impact factor: 5.128

Review 3.  Acute urinary retention: who is at risk and how best to manage it?

Authors:  Anand Patel; Christopher Chapple
Journal:  Curr Urol Rep       Date:  2006-07       Impact factor: 3.092

4.  The epidemiology of acute urinary retention in benign prostatic hyperplasia.

Authors:  C G Roehrborn
Journal:  Rev Urol       Date:  2001

5.  Rapid approximation of confidence intervals for Markov process decision models: applications in decision support systems.

Authors:  D J Cher; L A Lenert
Journal:  J Am Med Inform Assoc       Date:  1997 Jul-Aug       Impact factor: 4.497

Review 6.  Benign prostatic hyperplasia.

Authors:  R J Simpson
Journal:  Br J Gen Pract       Date:  1997-04       Impact factor: 5.386

Review 7.  Benign prostatic hyperplasia. Practical treatment guidelines.

Authors:  T Tammela
Journal:  Drugs Aging       Date:  1997-05       Impact factor: 3.923

8.  Acute urinary retention: risks and management.

Authors:  Claus G Roehrborn
Journal:  Rev Urol       Date:  2005

Review 9.  Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia.

Authors:  M I Wilde; A Fitton; D McTavish
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 10.  Finasteride. A review of its potential in the treatment of benign prostatic hyperplasia.

Authors:  D H Peters; E M Sorkin
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.